Uncategorized

Morgan Stanley resets Arista stock price target for 2026

Arista Networks spent the first quarter of 2026 in an unusual position. Investor conversations had gone quiet. Questions about customer concentration and margins were dominating the narrative. The stock was underperforming. That tone has shifted. And Morgan Stanley just put a number on how much it has shifted. Morgan Stanley raised target on Arista Networks […]

Morgan Stanley resets Arista stock price target for 2026 Read More »

Spirit Airlines shutdown triggers nearly 5,000 layoffs

Spirit Airlines suddenly shut down its operations on May 2, and now, following customer disruption and canceled flights, it has become a major layoff event. Especially in Florida, where the company is headquartered, the budget carrier’s collapse is hitting thousands of workers across airports and support operations. The Dania Beach-based airline revealed on May 2

Spirit Airlines shutdown triggers nearly 5,000 layoffs Read More »

Mark Cuban backs small businesses hiring a million new grads

Millions of college seniors will walk across graduation stages this spring, facing one of the toughest entry-level job markets in years. Large corporations have been pulling back on junior hiring while leaning heavily on artificial intelligence to fill roles once held by newcomers. Billionaire entrepreneur Mark Cuban has weighed in with a blunt and specific

Mark Cuban backs small businesses hiring a million new grads Read More »

Eli Lilly stock swings after FDA liver failure report for GLP-1 drug

Eli Lilly (LLY) stock initially sold off on Monday morning, May 4, after the FDA disclosed a liver failure report tied to the company’s new oral obesity drug Foundayo, but shares recovered as analysts argued the reaction may have been overdone. The episode shifted investor attention toward the long-term safety profile of Lilly’s oral GLP-1

Eli Lilly stock swings after FDA liver failure report for GLP-1 drug Read More »

Beyond Meat stock surge has investors asking one question

For most of the last year, investors essentially wrote off Beyond Meat (BYND). The formerly high-flying plant-based pioneer has gone from a pandemic-era darling to a heavily discounted brand battling dwindling sales, poor profitability and waning excitement for meat substitutes. Shares plummeted to penny-stock status, and for months it seemed like the tale had vanished.

Beyond Meat stock surge has investors asking one question Read More »